European Cardiac Biomarker Market Report 2021: By Key Players, Application, Type, Market Share, Forecast to 2027

The European cardiac biomarker market is estimated to grow significantly at a CAGR of around 7.1% during the forecast period. The cardiac biomarker market has a significant scope in the European region due to growing heart related diseases such as CVD, CHD, and stroke. Europe has the highest rates for CVD, CHD and other heart diseases which create a huge demand for diagnosis of cardiac diseases. Europe has a quality healthcare system and adopts the latest cardiology devices and technology to treat heart patients. Europe has a huge economic burden of heart related disease such as CVD, CHD, stroke and other heart diseases. Cardiac biomarkers can be used in the quick diagnosis of cardiac disease. Therefore, the rising incidence of CVD is expected to increase the demand for a cardiac biomarker in the region, which would prevail in the market.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/european-cardiac-biomarker-market

The market is segmented on the basis of type, application, and location of testing. Based on type, the market is segregated into Creatine kinase (CK-MB), Troponins (T, I), Myoglobin, Natriuretic peptides (BNP & NT-PROBNP), Ischemia modified albumin and Others. The troponin is anticipated to be the fastest growing and has a considerable market share in the European cardiac biomarker market due to easy and high sensitivity that results in the high adoption of the test. Based on Application, the market is segmented into myocardial infraction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. On the basis of the location of testing, the market is classified into laboratory testing and point of care testing.

Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/european-cardiac-biomarker-market

The companies which are contributing to the growth of the European cardiac biomarker market include Abbott Laboratories, BioMérieux S.A., Cisbio Bioassays SAS, Danaher Corp., F. Hoffmann-La Roche AG, HyTest Ltd, Merck KGaA, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.
Market Segmentation

European Cardiac Biomarker Market by Type
• Creatine kinase (CK-MB)
• Troponins(T,I)
• Myoglobin
• Natriuretic peptides (BNP & NT-PROBNP)
• Ischemia modified albumin
• Others

European Cardiac Biomarker Market by Application
• Myocardial infraction
• Congestive heart failure
• Acute coronary syndrome
• Atherosclerosis
• Others

European Cardiac Biomarker Market by Location of Testing
• Laboratory testing
• Point of care testing

Regional Analysis
• UK
• Germany
• France
• Italy
• Spain
• Rest of Europe

Company Profiles
• Abbott Laboratories
• BioMérieux S.A.
• Cisbio Bioassays SAS
• Danaher Corp.
• F. Hoffmann-La Roche AG
• HyTest Ltd
• Merck KGaA
• Randox Laboratories Ltd.
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-cardiac-biomarker-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.